HUB Organoids (HUB) is the global leader in the field of adult stem cell-derived organoid.
The technology invented by HUB’s scientists in the lab of world-renowned Prof. Hans Clevers represents a paradigm shift for drug discovery and development, preclinical patient stratification, predictive diagnostics, personalized medicine, clinical trials, regenerative medicine, and companion diagnostics.
HUB offers licenses to its proprietary technology and provides services and access to its living organoid biobanks.
Case study: drug discovery to clinical trials in 5 years
